StockNews.AI
HIMS
StockNews.AI
15 days

Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before August 25, 2025 to Discuss Your Rights - HIMS

1. Hims faces class action for allegedly misleading investors about product safety. 2. Claims include selling fake Wegovy, risking partnership with Novo Nordisk. 3. Shareholders from April to June 2025 are encouraged to register for the case. 4. The law firm aims to protect investor rights from deceit in business practices. 5. The deadline to seek lead plaintiff status is August 25, 2025.

5m saved
Insight
Article

FAQ

Why Very Bearish?

The allegations suggest significant legal risks that could severely affect HIMS's stock value. Historical examples show that companies facing class actions can experience sharp price declines due to litigation fears.

How important is it?

The class action raises serious concerns over HIMS’s business integrity and potential profitability, which is crucial for investor sentiment. The legal developments could significantly shape market perceptions and the stock's future performance.

Why Long Term?

The ongoing legal issues and potential termination of partnerships can impact HIMS's revenue and reputation over time. Similar cases, such as those faced by other health tech firms, have had extended repercussions.

Related Companies

NOVOPFEAMGN
, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=159218&from=4 CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Hims was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;" (2) as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. DEADLINE: August 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=159218&from=4 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HIMS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 25, 2025. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: [email protected]Phone: (646) 453-8903 SOURCE The Gross Law Firm WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News